Figure 3From: The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi Proportion of women with HIV-RNA < 1,000 copies/ml during follow-up. After 6 months only women on treatment were included in the analysis.Back to article page